Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001

被引:11
|
作者
Williams, AA
Parashar, UD
Stoica, A
Ridzon, R
Kirschke, DL
Meyer, RF
McClellan, J
Fischer, M
Nelson, R
Cartter, M
Hadler, JL
Jernigan, JA
Mast, EE
Swerdlow, DL
机构
[1] Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA
[2] Connecticut State Dept Publ Hlth, Hartford, CT USA
关键词
D O I
10.3201/eid0810.020399
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
On November 19, 2001, a case of inhalational anthrax was identified in a 94-year-old Connecticut woman, who later died. We conducted intensive surveillance for additional anthrax cases, which included collecting data from hospitals, emergency departments, private practitioners, death certificates, postal facilities, veterinarians, and the state medical examiner. No additional cases of anthrax were identified. The absence of additional anthrax cases argued against an intentional environmental release of Bacillus anthracis in Connecticut and suggested that, if the source of anthrax had been cross-contaminated mail, the risk for anthrax in this setting was very low. This surveillance system provides a model that can be adapted for use in similar emergency settings.
引用
收藏
页码:1078 / 1082
页数:5
相关论文
共 39 条
  • [31] Japanese triennial planned (An art exhibit in Yokohama, September-December 2001)
    Koplos, J
    ART IN AMERICA, 1999, 87 (11): : 41 - 41
  • [32] Laboratory aspects of bioterrorism-related anthrax - from identification to molecular subtyping to microbial forensics
    Popovic, T
    Glass, M
    CROATIAN MEDICAL JOURNAL, 2003, 44 (03) : 336 - 341
  • [33] Detection and prevention of ocular phototoxicity of ciprofloxacin, the prophylactic antidote for bioterrorism-related anthrax.
    Roberts, JE
    Rammal, M
    Smith, F
    Hamilton, MG
    Chignell, CF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U178 - U178
  • [34] Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax
    Quinn, CP
    Dull, PM
    Semenova, V
    Li, H
    Crotty, S
    Taylor, TH
    Steward-Clark, E
    Stamey, KL
    Schmidt, DS
    Stinson, KW
    Freeman, AE
    Elie, CM
    Martin, SK
    Greene, C
    Aubert, RD
    Glidewell, J
    Perkins, BA
    Ahmed, R
    Stephens, DS
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (07): : 1228 - 1236
  • [35] Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax (Reprinted from MMWR, vol 50, pg 941-948, 2001)
    Malecki, J
    Wiersma, S
    Cahill, T
    Grossman, M
    Hochman, H
    Tapper, M
    Pomeranz, M
    Friedman-Kien, A
    Gurtman, A
    Bresnitz, E
    DiFerdinando, G
    Lurie, P
    Nalluswami, K
    Frank, D
    Siegel, L
    Adams, S
    Walks, I
    Davies-Coles, J
    Chiriboga, C
    Brechner, R
    Peterson, E
    Bresoff-Matcha, S
    Galbraith, M
    Eisold, J
    Martin, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19): : 2392 - 2396
  • [36] Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018
    Person, Marissa K.
    Cook, Rachel
    Bradley, John S.
    Hupert, Nathaniel
    Bower, William A.
    Hendricks, Katherine
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S392 - S401
  • [37] Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis (Reprinted from MMWR, vol 50, pg 973-76, 2001)
    Malecki, J
    Wiersma, S
    Labinson, R
    Kamal, L
    Bresnitz, E
    Diferdinando, G
    Lurie, P
    Nalluswami, K
    Hathcock, L
    Siegel, L
    Adams, S
    Walks, I
    Davies-Coles, J
    Richardson, M
    Brechner, R
    Stroube, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20): : 2536 - 2537
  • [38] Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001 (Reprinted from MMWR, vol 50, pg 909-919, 2001)
    Malecki, J
    Wiersma, S
    Cahill, K
    Grossman, M
    Hochman, H
    Gurtman, A
    Bresnitz, E
    DiFerdinando, G
    Lurie, P
    Nalluswami, K
    Siegel, L
    Adams, S
    Walks, I
    Davies-Coles, J
    Brechner, R
    Peterson, E
    Frank, D
    Bresoff-Matcha, S
    Chiriboga, C
    Eisold, J
    Martin, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2226 - 2232
  • [39] Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and antimicrobial availability program for persons at risk for bioterrorism-related inhalational anthrax
    Tierney, BC
    Martin, SW
    Franzke, LH
    Marano, N
    Reissman, DB
    Louchart, RD
    Goff, JA
    Rosenstein, NE
    Sever, JL
    McNeil, MM
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (07) : 905 - 911